The incidence of type 2 diabetes, the most common cause of diabetic retinopathy (DR), is rapidly on the rise due to the overconsumption of calorie rich diets. Using an animal model of diet-induced obesity/pre-type 2 diabetes, we evaluated the mechanism responsible for increased O-GlcNAcylation of retinal proteins following consumption of a diet high in saturated fat (HFD), as dysregulated O-GlcNAcylation contributes to the development of DR. In the retina of mice fed a HFD for 4 weeks, increased O-GlcNAcylation was observed concomitant with markers of endoplasmic reticulum (ER) stress. Similarly, in TR-MUL retinal cells in culture, addition of the saturated fatty acid palmitate or the ceramide analog Cer6 to culture medium increased protein O-GlcNAcylation and ER stress. One potential mechanism whereby ER stress increases O-GlcNAcylation is by upregulating flux through the hexosamine biosynthetic pathway (HBP) via increased expression of the rate-limiting enzyme glutamine-fructose-6-phosphate amidotransferase (GFAT). In the retina of mice fed a HFD and in TR-MUL cells exposed to Cer6, mRNA and protein expression of GFAT2, but not GFAT1 were increased. Similarly, in TR-MUL cells treated with the ER stress inducer thapsigargin (TG) increased O-GlcNAcylation was observed concomitant with an increase in GFAT2. Alternatively, ER stress inhibitor prevented the effect. GFAT2 knockdown via siRNA attenuated O-GlcNAcylation induced by either TG or Cer6. The glial cell specific transcription factor OASIS (old astrocyte specifically-induced substance) plays a central role in coordinating the unfolded protein response. Unlike GFAT1, GFAT2 contains a putative binding site for OASIS. Both HFD and Cer6 increased OASIS expression, and OASIS was sufficient to promote GFAT2 expression and increase O-GlcNAcylation. Overall, the results support a model whereby HFD-induced ER stress acts to promote O-GlcNAcylation in retina through an OASIS/GFAT2-dependent mechanism.

Disclosure

W. Dai: None. A. Toro: None. S.K. Dierschke: None. M.D. Dennis: None.

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.